Overview Oral Contraceptive DDI Study Status: Unknown status Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women. Phase: Phase 1 Details Lead Sponsor: Lexicon PharmaceuticalsTreatments: (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triolContraceptive AgentsContraceptives, OralEstradiolEstradiol 17 beta-cypionateEstradiol 3-benzoateEstradiol valerateEthinyl EstradiolMoxifloxacinNorgestimateNorgestimate, ethinyl estradiol drug combinationPolyestradiol phosphate